In Vivo Contract Research Organization Market Growth Expected to Reach $7.77 Billion by 2030 with 8.1% CAGR
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The In Vivo Contract Research Organization Market During The Forecast Period 2026–2030?
The in vivo contract research organization market size has demonstrated significant growth in recent years. It is anticipated to increase from $5.23 billion in 2025 to $5.68 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.6%. This historical expansion can be linked to factors like rising pharmaceutical R&D spending, the broadening of biotechnology pipelines, the increasing complexity inherent in drug development, stricter regulatory mandates for preclinical data, and the availability of sophisticated animal models.
The in vivo contract research organization market size is projected to experience robust expansion over the coming years. It is anticipated to reach $7.77 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.1%. This projected growth during the forecast period stems from factors such as increasing demand for faster drug development timelines, rising use of advanced in vivo disease models, expansion of oncology and rare disease research, growing adoption of AI-enabled preclinical analytics, and increasing regulatory scrutiny of safety data. Significant trends expected in this forecast period include increasing outsourcing of preclinical research activities, rising demand for specialized disease models, growing adoption of GLP-compliant toxicology studies, expansion of integrated preclinical service offerings, and an enhanced focus on data quality and reproducibility.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25790&type=smp
What Underlying Factors Are Accelerating The Growth Of The In Vivo Contract Research Organization Market?
The expanding emphasis on personalized medicine is projected to drive the expansion of the in vivo contract research organization market in the future. This medical strategy involves customizing treatment and prevention methods based on an individual’s genetic profile, lifestyle choices, and environmental factors to enhance health results. This heightened attention to personalized medicine stems from the improved accessibility and cost-effectiveness of genomic sequencing technologies. These technological advancements facilitate more precise detection of genetic mutations, which in turn allows for customized treatments that lead to better patient outcomes and minimize experimental approaches in therapy. The increasing concentration on personalized medicine is fueling demand within the in vivo CRO market, given the necessity for bespoke preclinical studies employing particular animal models to assess targeted therapies and their impact on unique genetic profiles. For example, data from February 2024, provided by the Personalized Medicine Coalition (PMC), a US-based nonprofit, revealed that the FDA sanctioned 16 new personalized treatments in 2023, a rise from six in 2022. For the fourth consecutive year, personalized medicines constituted over one-third of all novel drug approvals by the U.S. Food and Drug Administration (FDA). Consequently, the intensifying focus on personalized medicine is a key driver for the growth of the in vivo contract research organization market.
What Market Segments Are Evaluated Within The In Vivo Contract Research Organization Market?
The in vivo contract research organization market covered in this report is segmented –
1) By Type: Rodent Based, Non-Rodent Based
2) By Type Of Service: Translational And IND-Enabling In Vivo Studies, Preclinical Services, Post-Approval Nonclinical Safety And Mechanistic Studies
3) By Good Laboratory Practice Type: Good Laboratory Practice Toxicology, Non Good Laboratory Practice
4) By Applications: Oncology, Cardiovascular Diseases, Infectious Diseases, Neurological Disorders, Other Applications
5) By End User: Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Academic And Research Institutes, Government And Regulatory Bodies
Subsegments:
1) By Rodent-Based: Mice Models, Rat Models, Genetically Engineered Rodents, Immunodeficient Rodents, Humanized Rodents
2) By Non-Rodent-Based: Canine Models, Non-Human Primate Models, Swine Models, Rabbit Models, Zebrafish Models
Which Market Trends Are Creating New Opportunities In The In Vivo Contract Research Organization Market?
Leading companies within the in vivo contract research organization market are concentrating on developing innovative solutions, such as advanced therapy incubator programs, to accelerate the progress of next-generation therapeutics and support early-stage clinical research. An advanced therapy incubator program represents a specialized undertaking designed to assist early-stage biotechnology companies by providing resources, mentorship, and infrastructure to speed up the development of advanced therapies like gene, cell, and RNA-based treatments. For instance, in April 2025, Charles River Laboratories International Inc., a US-based pharmaceutical company, launched its inaugural advanced therapy incubator program cohort. This pioneering initiative is designed to support early-stage biotech companies focused on evolving next-generation therapies. Through the program, participants gain access to Charles River’s scientific expertise, state-of-the-art laboratory infrastructure, and customized in vivo models, enabling them to rapidly generate proof-of-concept data. The program also offers a practical preclinical setting for validating therapeutic candidates, helping to shorten time-to-clinic and improve the likelihood of regulatory success. By bridging the gap between academic innovation and clinical development, this initiative plays a crucial role in advancing the field of advanced therapies.
Who Are The Top Market Participants Influencing The In Vivo Contract Research Organization Market?
Major companies operating in the in vivo contract research organization market are Thermo Fisher Scientific Inc, Labcorp Drug Development Inc, Eurofins Scientific SE, WuXi AppTec, Charles River Laboratories International Inc, Evotec SE, GemPharmatech Co Ltd, BIOQUAL Inc, Crown Bioscience Inc, PsychoGenics Inc, Janvier Labs SAS, Taconic Bioscience Inc, Xentech SAS, Altogen Labs Inc, AniLocus Inc, Pharmaron Beijing Co Ltd, Southern Research Institute, SRI International, Envigo RMS LLC, Horizon Discovery Group plc, Inotiv Inc, GenScript ProBio
Read the full in vivo contract research organization market report here:
Which Region Is Projected To Dominate The In Vivo Contract Research Organization Market During The Forecast Period?
North America was the largest region in the in vivo contract research organization market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vivo contract research organization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored In Vivo Contract Research Organization Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=25790&type=smp
Browse Through More Reports Similar to the Global In Vivo Contract Research Organization Market 2026, By The Business Research Company
Biologics Contract Development Global Market Report
Medical Device Contract Manufacturing Global Market Report
Contract Development Manufacturing Organizations Global Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
